Why the study?
Dobutamine-associated eosinophilia, fever, and eosinophilic myocardial hypersensitivity carry a substantial risk of severe sequelae stemming from diagnostic delay.
Dobutamine can cause acute eosinophilia and eosinophilic myocardial hypersensitivity, requiring prompt recognition and discontinuation to prevent progressive cardiac deterioration.
Answers are grounded in this paper and cite their sources.
Rising eosinophils on prolonged dobutamine may avert decompensation if recognized early; leaves open safer inotrope alternatives.
This report of dobutamine-associated eosinophilia, fever, and eosinophilic myocardial hypersensitivity illustrates the substantial risk of severe sequelae stemming from diagnostic delay. Recognition of this rare condition should catalyze exploration for feasible dobutamine alternatives, thereby minimizing morbidity and optimizing outcomes.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: